Qube Research & Technologies (QRT)
IRLA

Qube Research & Technologies (QRT)’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio IRLA Stock Details IRLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-392
Closed -$263K – 4005
2025
Q4 		$263K Buy
+392
New +$197K ﹤0.01% 2993
2022
Q4 		– Sell
-68
Closed -$18K – 2893
2022
Q3 		$18K Sell
68
-53
-44% -$20.2K ﹤0.01% 2311
2022
Q2 		$54K Buy
+121
New +$85.5K ﹤0.01% 2105

Other funds holding IRLA

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Qube Research & Technologies (QRT)'s IRLA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q1 2026, closing a stake of 392 shares — an estimated $263K sold.

Qube Research & Technologies (QRT) first reported a position in IRLA in Q2 2022 and held it in 3 quarters. The position peaked at $263K in Q4 2025. 43 funds tracked by Wall St. Rank hold IRLA as of Q1 2026.

  • Qube Research & Technologies (QRT) reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q1 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 392 IRulya Therapeutics Inc. Common Stock shares in Q1 2026, an estimated $263K.
  • Qube Research & Technologies (QRT) first reported a position in IRulya Therapeutics Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s IRulya Therapeutics Inc. Common Stock position peaked at $263K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.